Unicorn Fund bought 67,200 shares of Accretion Pharmaceuticals for ₹69 lakh at ₹102.60 apiece in a bulk deal on April 29, 2026.
A pharmaceutical manufacturer incorporated in 2012, Accretion Pharmaceuticals produces tablets, capsules, and other healthcare products for domestic and international markets. The company operates across multiple therapeutic segments, focusing on formulation development, quality manufacturing, and distribution. Its distinctive strength lies in vertically integrated operations combining research capabilities with modern production facilities and a wide distribution network across India and select overseas regions.
Ahmedabad-based with positions across smallcap and midcap listed equities.